Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard Extended Market ETF (NY:VXF)

244.24 +0.29 (+0.12%)
Streaming Delayed Price Updated: 1:32 PM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study ↗
Via Stocktwits
Professional Diversity Network Stock Exploded Over 400% Today – Here’s An Update ↗
Via Stocktwits
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later ↗
Via Stocktwits
Soho House Nears $9-Share Go-Private Deal: Report ↗
Via Stocktwits
News headline image
Workhorse Group To Merge With Motive Electric Trucks: Retail’s Divided On The Combined Company Valuation ↗
The combination will create a leading North American medium-duty electric truck original equipment manufacturer with a full range of Class 4-6 trucks valued at about $105 million, the companies said. 
Via Stocktwits
Topics Electric Vehicles
News headline image
Verb Technology Stock Nearly Doubles On Monday, Retail Chatter Explodes A Whopping 1,100%: Here’s What’s Happening ↗
Following the closing of a private placement, expected on or around August 7, the company will operate under the name TON Strategy Co. (TSC). 
Via Stocktwits
Imunon Doses First Patient With Experimental Cancer Drug In Late-Stage Trial: Retail Thinks Company Is Undervalued ↗
Via Stocktwits
American Airlines Sparks Investor Debate After Q2 Beat, Cautious Outlook: Retail’s On Buying Spree ↗
Via Stocktwits
Wendy's Announces 190 New Burger Chain Outlets In Italy and Armenia: Retail View Turns Bullish ↗
Via Stocktwits
Stitch Fix Surges After William Blair Upgrade: Retail Still On The Fence ↗
Via Stocktwits
Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant ↗
Via Stocktwits
News headline image
Robinhood CEO Reportedly Defends OpenAI, SpaceX Tokens – Says Equity Is Not ‘Entirely Relevant’ ↗
Robinhood CEO Vlad Tenev defended offering stock tokens for OpenAI and SpaceX, saying equity status is secondary to giving retail investors access. 
Via Stocktwits
Topics ETFs Government
News headline image
BofA Lowers Crocs Price Target, But Keeps 'Buy' Rating On Potential Upside In Foreign Market ↗
Crocs' Q1 revenue and profit for the last quarter were above expectations, but the company withdrew its full-year 2025 outlook in May. 
Via Stocktwits
Topics World Trade
News headline image
Robinhood Launches Tokens For EU Users To Trade US Stocks ↗
Robinhood is expanding into Europe with tokenized stocks, crypto futures, and staking, aiming to merge traditional and digital assets through a mobile-first, blockchain-powered investment platform. 
Via Stocktwits
Topics Derivatives ETFs Lawsuit
News headline image
Cineverse Stock Soars As Terrifier 3 Lifts Q4 Revenue: Retail Optimism Abounds ↗
Cineverse Q4 revenue jumped 58% to $15.6 million, driven by Terrifier 3, with EPS and EBITDA exceeding expectations. 
Via Stocktwits
Topics Artificial Intelligence Government
News headline image
Cyngn Stocks Soars On Nvidia Partnership, Robotics Showcase ↗
The collaboration showed off Cyngn’s integration of the Nvidia Isaac robotics platform to advance its autonomous vehicle technology tailored for industrial environments. 
Via Stocktwits
Topics Artificial Intelligence Earnings
News headline image
Sonim Technologies Stock Surges On AI Merger Plans With HPC Firm: Retail Turns Optimistic ↗
Shareholders of the AI infrastructure company would control a majority interest in the combined organization, while Sonim investors would retain equity worth approximately $17.5 million. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Nektar Therapeutics Announces Positive Data From Eczema Drug In Mid-stage Trial: Stock More Than Doubles But Retail Sees It Rising Further ↗
Nektar Therapeutics said its mid-stage trial showed that patients who received Rezpegaldesleukin demonstrated improvement in eczema area and severity score compared to placebo at week 16. 
Via Stocktwits
Topics Economy Government
News headline image
Cidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage Trial ↗
Single doses of 450mg, 300mg, and 150mg of CD388 conferred 76%, 61%, and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo, the company said. 
Via Stocktwits
News headline image
SeaStar Medical Stock Tanks At Discounted Pricing Of Public Offering, Retail Believes Company Is Inching Closer To Bankruptcy ↗
The public offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday. 
Via Stocktwits
Topics Bankruptcy
News headline image
NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline ↗
The newly announced partnership aims to develop SIM0505, a novel antibody-drug conjugate developed by Simcere Zaiming for the treatment of solid tumors. 
Via Stocktwits
News headline image
Sonim Technologies Stock Doubles After Company Confirms DOOGEE's Acquisition Proposal, Retail Goes All In ↗
Sonim’s Special Committee, tasked with overseeing strategic alternatives, acknowledged the proposal but noted that it lacks the information needed to properly assess the offer. 
Via Stocktwits
News headline image
Curiosity’s New Global Content, AI Licensing Deals Fail To Lift Retail Mood ↗
Curiosity expands global reach through new international licensing deals across broadcasters and platforms, while tapping into AI training markets with its vast library of factual video and audio... 
Via Stocktwits
Topics Artificial Intelligence
News headline image
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause ↗
Under the distribution agreement, Recon Supply will distribute ReShape’s portfolio across the Veterans Administration and Department of Defense healthcare systems. 
Via Stocktwits
News headline image
Retail Goes Gaga Over Inuvo Shares On Upbeat Q2 Outlook, Reverse Stock Split Plans ↗
Inuvo expects at least 25% revenue growth in the second quarter and completed a 1-for-10 reverse stock split to boost stock liquidity and attract more institutional investors. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Tonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not Pessimistic ↗
The proceeds from the purchase agreement are expected to be used for working capital and general corporate purposes. 
Via Stocktwits
News headline image
Intelligent Bio Rises On Partnership With Smartox To Expand US Market Presence: Retail Hopes The Stock To Hit $2.6 ↗
Intelligent Bio is actively pursuing FDA clearance for its opiate test system for codeine, utilizing its fingerprint sweat-based testing technology. 
Via Stocktwits
News headline image
Stitch Fix's Forecast Bump After Strong Q3 Print Lifts Shares And Retail Sentiment ↗
The company reported progress on its turnaround strategy. 
Via Stocktwits
News headline image
Ernexa Stock Drops On 1-For-15 Reverse Stock Split To Regain Nasdaq Compliance: Retail Sentiment Improves But Stays Bearish ↗
As of Tuesday, the company had 110.4 million shares of common stock issued and outstanding, which it anticipates will result in approximately 7.4 million shares on a split-adjusted basis. 
Via Stocktwits
News headline image
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism ↗
The offer price of $2.50 represents a 40% discount to the stock’s closing price of $4.18 on Friday. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.